BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16284300)

  • 1. PMS2 mutations in childhood cancer.
    Bonthron DT; Hayward BE; De Vos M; Sheridan E
    Gut; 2005 Dec; 54(12):1821. PubMed ID: 16284300
    [No Abstract]   [Full Text] [Related]  

  • 2. Constitutional mismatch repair deficiency presenting in childhood as three simultaneous malignancies.
    Walter AW; Ennis S; Best H; Vaughn CP; Swensen JJ; Openshaw A; Gripp KW
    Pediatr Blood Cancer; 2013 Nov; 60(11):E135-6. PubMed ID: 23729388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A homozygous PMS2 founder mutation with an attenuated constitutional mismatch repair deficiency phenotype.
    Li L; Hamel N; Baker K; McGuffin MJ; Couillard M; Gologan A; Marcus VA; Chodirker B; Chudley A; Stefanovici C; Durandy A; Hegele RA; Feng BJ; Goldgar DE; Zhu J; De Rosa M; Gruber SB; Wimmer K; Young B; Chong G; Tischkowitz MD; Foulkes WD
    J Med Genet; 2015 May; 52(5):348-52. PubMed ID: 25691505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple pilomatricomas with somatic CTNNB1 mutations in children with constitutive mismatch repair deficiency.
    Chmara M; Wernstedt A; Wasag B; Peeters H; Renard M; Beert E; Brems H; Giner T; Bieber I; Hamm H; Sciot R; Wimmer K; Legius E
    Genes Chromosomes Cancer; 2013 Jul; 52(7):656-64. PubMed ID: 23629955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation.
    Nakagawa H; Lockman JC; Frankel WL; Hampel H; Steenblock K; Burgart LJ; Thibodeau SN; de la Chapelle A
    Cancer Res; 2004 Jul; 64(14):4721-7. PubMed ID: 15256438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homozygous PMS2 germline mutations in two families with early-onset haematological malignancy, brain tumours, HNPCC-associated tumours, and signs of neurofibromatosis type 1.
    Krüger S; Kinzel M; Walldorf C; Gottschling S; Bier A; Tinschert S; von Stackelberg A; Henn W; Görgens H; Boue S; Kölble K; Büttner R; Schackert HK
    Eur J Hum Genet; 2008 Jan; 16(1):62-72. PubMed ID: 17851451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline PMS2 mutations: one hit or two?
    Gryfe R; Gallinger S
    Gastroenterology; 2005 May; 128(5):1506-9. PubMed ID: 15887130
    [No Abstract]   [Full Text] [Related]  

  • 8. PMS2 mutations in HNPCC.
    Hayward BE; De Vos M; Sheridan E; Bonthron DT
    Clin Genet; 2004 Dec; 66(6):566-7; author reply 568. PubMed ID: 15521988
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of hPMS1 and hPMS2 in predisposing to colorectal cancer.
    Liu T; Yan H; Kuismanen S; Percesepe A; Bisgaard ML; Pedroni M; Benatti P; Kinzler KW; Vogelstein B; Ponz de Leon M; Peltomäki P; Lindblom A
    Cancer Res; 2001 Nov; 61(21):7798-802. PubMed ID: 11691795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clearer picture of PMS2-associated lynch syndrome is emerging.
    Daniels MS; Lu KH
    J Clin Oncol; 2015 Feb; 33(4):299-300. PubMed ID: 25534383
    [No Abstract]   [Full Text] [Related]  

  • 11. Café-au-lait macules and pediatric malignancy caused by biallelic mutations in the DNA mismatch repair (MMR) gene PMS2.
    Jackson CC; Holter S; Pollett A; Clendenning M; Chou S; Senter L; Ramphal R; Gallinger S; Boycott K
    Pediatr Blood Cancer; 2008 Jun; 50(6):1268-70. PubMed ID: 18273873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood T-cell non-Hodgkin's lymphoma, colorectal carcinoma and brain tumor in association with café-au-lait spots caused by a novel homozygous PMS2 mutation.
    Kratz CP; Niemeyer CM; Jüttner E; Kartal M; Weninger A; Schmitt-Graeff A; Kontny U; Lauten M; Utzolino S; Rädecke J; Fonatsch C; Wimmer K
    Leukemia; 2008 May; 22(5):1078-80. PubMed ID: 18007577
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
    Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
    J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal Findings in the Largest Series of Patients With Hereditary Biallelic Mismatch Repair Deficiency Syndrome: Report from the International Consortium.
    Aronson M; Gallinger S; Cohen Z; Cohen S; Dvir R; Elhasid R; Baris HN; Kariv R; Druker H; Chan H; Ling SC; Kortan P; Holter S; Semotiuk K; Malkin D; Farah R; Sayad A; Heald B; Kalady MF; Penney LS; Rideout AL; Rashid M; Hasadsri L; Pichurin P; Riegert-Johnson D; Campbell B; Bakry D; Al-Rimawi H; Alharbi QK; Alharbi M; Shamvil A; Tabori U; Durno C
    Am J Gastroenterol; 2016 Feb; 111(2):275-84. PubMed ID: 26729549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype associated with recessively inherited mutations in DNA mismatch repair (MMR) genes.
    de Vos M; Hayward B; Bonthron DT; Sheridan E
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):718-20. PubMed ID: 16042583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms underlying mismatch repair deficiencies in normal cells.
    Moliaka YK; Cella M; Chudina AP; Kolesnikova TN; Terracciano L; Cathomas G; Bochkov NP; Buerstedde JM
    Genes Chromosomes Cancer; 1997 Nov; 20(3):305-9. PubMed ID: 9365839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline mutation and protein expression analysis of mismatch repair genes MSH6 and PMS2 in Malaysian Lynch syndrome patients.
    Zahary MN; Kaur G; Hassan MR; Sidek AS; Singh H; Yeh LY; Ankathil R
    Int J Colorectal Dis; 2014 Feb; 29(2):261-2. PubMed ID: 24072394
    [No Abstract]   [Full Text] [Related]  

  • 18. A PMS2-specific colorectal surveillance guideline.
    ten Broeke SW; Nielsen M
    Genet Med; 2015 Aug; 17(8):684. PubMed ID: 26240978
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma.
    Hicks SC; Ward RL; Hawkins NJ
    Pathology; 2011 Jan; 43(1):84-5; author reply 85-6. PubMed ID: 21240077
    [No Abstract]   [Full Text] [Related]  

  • 20. Homozygous PMS2 deletion causes a severe colorectal cancer and multiple adenoma phenotype without extraintestinal cancer.
    Will O; Carvajal-Carmona LG; Gorman P; Howarth KM; Jones AM; Polanco-Echeverry GM; Chinaleong JA; Günther T; Silver A; Clark SK; Tomlinson I
    Gastroenterology; 2007 Feb; 132(2):527-30. PubMed ID: 17258725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.